Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up (Q43172063)
Jump to navigation
Jump to search
scientific article published on 5 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up |
scientific article published on 5 February 2010 |
Statements
1 reference
Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up (English)
1 reference
Karin Jirström
1 reference
Olle Stål
1 reference
Lisa Rydén
1 reference
Monica Haglund
1 reference
Mårten Fernö
1 reference
5 February 2010
1 reference
1 reference
Identifiers
1 reference